The global market for endocrine system drugs is expected to grow at a CAGR of 6.0% during the forecast period. Endocrine drugs are medications that target a malfunctioning endocrine system. The increasing prevalence of the endocrine disease is a major factor driving the global endocrine system drugs market. Endocrine gland disorders such as Addison’s disease, gigantism, goitre, Cushing’s syndrome, polycystic ovary syndrome (PCOS), and diabetes among others are some key disorders associated with the endocrine system.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/endocrine-system-drugs-market
The growing adolescent population is expected to drive the demand for endocrine system drugs, as they are more susceptible to these diseases due to hormonal imbalances. Novo Nordisk A/S, Eli Lilly and Company, and Novartis International AG are among the market’s major players. To stay competitive in the market, market players are using a variety of strategies such as mergers and acquisitions, geographical expansion, partnerships and collaborations, and new product launches to contribute significantly to market growth.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
o By Type
o By Application
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Novo Nordisk A/S, Eli Lilly and Company, and Novartis International AG, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Endocrine System Drugs Market Report Segment
By Type
- Diabetes Drugs
- Human Growth Hormones
- Thyroid Hormone Disorder Drugs
By Application
- Hospitals
- Clinics
- Medical centers
A full report of Endocrine System Drugs Market is available at: https://www.omrglobal.com/industry-reports/endocrine-system-drugs-market
Endocrine System Drugs Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- AbbVie Inc.
- Alacer Corp.
- AstraZeneca Plc
- Eli Lilly Co.
- Hoffman La Roche Ltd.
- Facet Biotech Corp.
- Merck Group
- Novo Nordisk A/S
- Sanofi SA
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
